Abbott to Present at J.P. Morgan Healthcare Conference

ABBOTT PARK, Ill., Dec. 18, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2015. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at 10:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the presentation will be available later that day.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbott-to-present-at-jp-morgan-healthcare-conference-300010308.html

SOURCE Abbott

Suggested Articles

After Purdue’s record opioid settlement, more deals could be on the way. But that doesn’t mean all defendants are prepared to go quietly.

Now in their third quarter on the market, Gilead's own Epclusa and Harvoni generics have together grabbed more than 20% of the U.S. hep C market.

Purdue is seeking bankruptcy after inking a $10 billion-plus opioid settlement with thousands of cities and counties, plus two dozen states.